2m 2m 2m 2m 2m 2m 2m
Burzynski Resear (BZYR)
OTC
$0.006+$0.0010 (+12.73%)
Price as of Jun 23, 2026- $1.1MMarket Cap
- -77.03%1-Year Change
- BiotechnologyIndustry
Burzynski Resear (BZYR)
$0.006+$0.0010 (+12.73%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 0
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.006
$0.006
$0.006
1-Year Range
$0.006
$0.06
$0.006
Latest Close$0.006
Change
-$0.002 (-39.34%)
Volume3,300
Market Cap$1.1M
Shares Outstanding131.4M
P/E (TTM)-0.87
Diluted EPS (TTM)-$0.010
Enterprise Value$1.1M
Information as of 06/23/2026
Company Profile
BURZYNSKI RESEARCH INSTITUTE INC
https://propcitweb.ddns.net:83$1.1M
Market Cap
-$1.3M
Net Income
Sector: Healthcare
Industry: Biotechnology
9432 Katy Freeway, Houston, TX, United States, 77055
713 335 5697Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Key Executives
- Tomasz Janicki
- Stanislaw R. Burzynski
- Patryk Goscianski
Current Ownership Distribution
- Other131.4M (99.98%)
- Institutions29,000 (0.02%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)